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 INTRODUCTION 
Preeclampsia is a disease with worldwide significance to 
mothers and infants and it is a leading cause of death and 
disability in mothers and infants.1,2  This disorder was first 
recognized almost 2000 years ago. Celsus described pregnant 
women with seizures that abated with delivery. This disorder was 
termed eclampsia and for 2000 years, was considered a pregnancy 
specific seizure disorder.  
In the late 1800’s the association of, initially, proteinuria and 
later increased blood pressure with eclampsia was recognized. It 
was also noted that increased blood pressure and urinary protein 
antedated seizures. From this came the term pre-eclampsia 
(Chesley, L.C. 1978).3
According to WHO estimates, about 510,000 maternal deaths 
(about 0.9 percent of total deaths) occurred globally during the year 
2002, of these  deaths about 1,71,000 were in South East Asian 
Countries.4  Most of the maternal deaths are preventable. The life-
time chances of maternal death in the world as a whole is 1 in 75. It 
varies from region to region and from country to country. In India, 
the life-time risk of maternal death for mother is 1 in 61.5,6,7 
Estimates of Maternal Mortality  in some countries are given 
below 
ESTIMATES OF MATERNAL MORTALITY7,8
Country 
Maternal Mortality 
(Per 1,00,000 live births) 
India 307 
Srilanka 92 
Bangladesh 380 
Nepal 740 
Myanmar 360 
Thailand 44 
China 56 
Japan 10 
Singapore 15 
U.K. 11 
USA 14 
Switzerland 7 
 Causes of maternal death worldwide are Obstetric 
Haemorrhage 25%, Infection 15%, Eclampsia 12%, Obstructed 
labour 8%, Unsafe Abortion 13%, Other direct causes 8%, Indirect 
causes 20%. 
Most common causes of Maternal death in India (2006)9 are 
Haemorrhage 29%, Anemia 19%, Sepsis 16%, Obstructed labour 
10%, Abortion 9%, Toxemia 8% and others 9%. 
The current  maternal mortality ratio in Tamil Nadu (2006) 
is 92/100,000 live births. (NFHS III)10
For many years diet has been suggested to play a role in pre-
eclampsia.3 Nutritional deficiencies of both macro and 
micronutrients are common in women of reproductive age group in 
developing countries. Epidemiological and biological evidence 
suggest that acute or chronic specific nutritional deficiencies can 
contribute to severe maternal morbidity.  
A role of altered calcium metabolism in the pathogenesis of 
pre-eclampsia has been suggested based on epidemiological 
evidence linking low dietary levels of calcium and increased 
incidence of the disease.11,12
Magnesium is one of the essential minerals needed by 
humans in relatively large amounts. Dietary surveys during 
pregnancy consistently demonstrate that many women, especially 
those from disadvantaged backgrounds, have intakes of magnesium 
below the recommended levels. Observational studies from medical 
records reported that magnesium supplementation during 
pregnancy was associated with reduced risk of pre-eclampsia.12  
In this above background, it is desirable to know the serum 
levels of magnesium and  calcium in Indian pregnant women. It 
may give some clue whether routine monitoring of serum 
magnesium and calcium may have potential in the a) early 
detection of pregnant women at risk of pre-eclampsia13  
b)  monitoring the progress of diverse therapeutics during clinical 
management14 or c) Prophylactic calcium and Magnesium 
supplementation during pregnancy could be recommended.15 
REVIEW OF LITERATURE 
Sukonpan K, Phupong V16 conducted a study with the aim of 
measuring serum levels of calcium and magnesium in pre-
eclamptic pregnancies and to compare them with those in normal 
pregnancies. Venous serum samples were collected from 40 
preeclamptic women and 40 normal pregnant women. The blood 
samples were analyzed for calcium and magnesium. The results 
were statistically analyzed. The serum calcium concentration in pre 
eclamptic pregnant women is significantly lower than that in 
normal pregnant women (9.0 ± 0.14 mg / dl vs 9.7 ± 0.7 mg / dl, P < 
0.0001). Like serum calcium, serum magnesium concentration in 
preeclamptic women is significantly  lower than that in normal 
pregnant women (0.77 ± 0.08  mmol/L vs 0.85 ± 0.09 mmol/L, P = 
0.001).  
The conclusion of the study is that both serum calcium and 
serum magnesium levels in preeclamptic pregnant women are 
lower than in normal pregnant women. 
SR Ambwani, UH Shah et al.,15 conducted a prospective case 
controlled study to find out the role of electrolytes, (magnesium and 
calcium) in the pathophysiology of hypertension during pregnancy. 
The serum magnesium concentration in preeclamptics were lower 
than the normotensive pregnant women (1.34 ± 0.06 meq/L, Vs  
2.06 ± 0.67 meq/L, P < 0.001). The serum calcium concentration in 
preeclamptics were lower than the normotensive pregnant women 
(7.76 ± 0.37 mg/dl Vs 9.24 ± 0.15 mg/dl P < 0.01). Findings from this 
study showed a significant decrease in serum level of magnesium 
and calcium in preeclamptic women.  
Qi Q, Li W et al.,17 evaluated the magnesium and calcium 
concentrations of serum in patients with Pregnancy Induced 
Hypertension. 26 patients with Pregnancy Induced Hypertension 
and 27 healthy women in their late pregnancy were studied. The 
serum magnesium and calcium contents were measured.  When 
compared with healthy women in their late pregnancy, the serum 
magnesium and calcium contents in patients with Pregnancy 
Induced Hypertension decreased significantly (P < 0.01 and P < 
0.05). 
Kisters K, Barenbrock M et al.,18 studied the changes in 
calcium and magnesium metabolism in normal pregnancy and pre 
eclampsia. Plasma, intracellular and membrane calcium and 
magnesium concentrations were determined. Twenty five controls, 
18 untreated healthy pregnant and 16 nullipara preeclamptic 
women were investigated.  Plasma, intracellular magnesium 
concentration were significantly lower in the preeclamptic group as 
compared to controls (P < 0.01).  The erythrocyte membrane 
magnesium content was found to be  significantly decreased in the 
preeclamptic women as compared to healthy subjects (P <  0.001). 
There was a significant decrease in the plasma calcium 
concentration in the preeclamptic group compared to controls or 
healthy pregnant women (P < 0.05). Membranous calcium content 
was significantly increased in the preeclamptic group versus 
controls or healthy pregnant women (P < 0.001) and an inverse 
correlation with membranous magnesium content was found (r = -
0.79, P < 0.01). Lowered plasma, intracellular and membrane 
magnesium concentrations in preeclamptic may contribute to the 
development of hypertension in pregnancy. In addition, a disturbed 
calcium homeostasis is observed in preeclampsia.  
Kisters K, Louwen F et al,19 investigated the changes in 
calcium and magnesium metabolism in normal pregnancy and pre 
eclampsia. Plasma calcium and magnesium concentrations were 
determined. 22 untreated healthy pregnant women and 20 
preeclamptic women were investigated. In each patient, plasma 
calcium and magnesium contents were measured. The results of 
the study are plasma magnesium concentration was significantly 
lowered in preeclamptic group as compared to control subjects (P < 
0.0001). There was a significant decrease in the plasma calcium 
concentrations of the preeclamptic group as compared to healthy 
pregnant women, (P < 0.05). Additionally, a disturbed calcium 
homeostasis is observed in preeclampsia.  
Sulaiman S, Adeeb N et al.,20 determined total calcium, total 
magnesium in pregnant normotensive, pregnancy induced 
hypertension and preeclampsia women. Total calcium levels were of 
lower levels (P < 0.05) in pregnancy induced hypertension women 
and preeclampsia women compared to normotensive pregnant 
women. 
Huang Y, Zhang W et al., 21 studied magnesium and calcium 
levels of plasma before and after magnesium sulfate treatment in 
patients with pregnancy induced hypertension. The calcium and 
magnesium levels in plasma of 36 patients with PIH and 14 
healthy gravidi in their late pregnancy were determined and the 
calcium and magnesium levels after 4 hours infusion of magnesium 
sulphate also were determined. 
The results of the study is plasma calcium and magnesium 
decreased significantly in moderate and severe Pregnancy Induced 
Hypertension patients. After magnesium sulphate infusion for 
Pregnancy Induced Hypertension, magnesium and calcium levels in 
plasma increased. The conclusion of the study is that magnesium 
deficiency is the basis of calcium and magnesium disturbances in 
PIH, and magnesium sulphate treatment may improve the 
situation effectively.  
Kumru S, Aydin S et al.,13 did a comparative study of serum 
calcium and magnesium levels in preeclamptic and healthy 
pregnant women. Samples were collected from 30 pre eclamptic and 
30 healthy pregnant women. The serum calcium levels were lower 
in the preeclamptic women (P < 0.001), whereas the serum 
magnesium concentration showed statistically insignificant 
differences between the two groups. Measurement of these 
elements may be useful for the early diagnosis of preeclampsia. 
Smolarczyk R, Romejko et al.,22 studied serum concentrations 
of calcium and magnesium in women with pregnancy induced 
hypertension. Study group consisted of 63 women in the III 
trimester of pregnancy, 32 subjects with Pregnancy Induced 
Hypertension (investigated group) were compared to control group  
consisted of 30 healthy patients with uneventful course of 
gestation. Concentrations of calcium and magnesium in serum were 
determined. It was stated that due to renal impairment observed 
during Pregnancy Induced Hypertension, calcium urine excretion 
and calcium concentration in serum decreased in the course of  
Pregnancy Induced Hypertension. 
Standley CA, Whitty JE et al., 23 did a study to compare the 
serum levels of ionized and total magnesium and ionized calcium 
and total  calcium over the course of pregnancy in normal pregnant 
women and in women who develop pre eclampsia. Venous serum 
samples from 31 pregnant women during their first, second and 
third trimesters were collected. Samples were analyzed for ionized 
and total magnesium, ionized and total calcium. In 22 normal 
pregnant women, both serum ionized and total magnesium levels 
decreased significantly with increasing gestational age. No changes 
in ionized or total calcium were observed. Nine of the 31 subjects 
developed pre eclampsia by term; serum total magnesium levels 
decreased significantly by the second trimester in these women 
compared with those of normal pregnant women. Their results 
provide evidence of decrease in ionized and total magnesium levels 
with increasing gestational age during normal pregnancy, as well 
as evidence of a magnesium deficiency in women who later develop 
preeclampsia.  
Zhao F.,24 studied calcium and magnesium contents of the 
maternal serum in women with pregnancy  induced hypertension. 
Calcium and magnesium in the maternal serum were measured in 
106 patients suffering from Pregnancy Induced Hypertension and 
106 controls (normal pregnant women). Mean maternal serum 
values of Calcium and Magnesium in the PIH group were 2.46 
mmol/L, 0.839 mmol/L respectively and were compared with the 
corresponding values of 2.765 mmol/L, 0.834 mmol/L in the 
controls. The calcium levels were lower in the PIH group (P < 0.05 
or P < 0.01). This study suggests that maternal serum calcium 
levels are related to Pregnancy Induced Hypertension and calcium 
might have a causal role in the development of Pregnancy Induced 
Hypertension. 
Isezuo SA, EKele BA.,25 did a study to determine if eclampsia 
is associated with low serum calcium. Serum calcium and  
magnesium were compared among 30 intrapartum eclamptics and 
30 age, parity and gestational age matched women with 
uncomplicated pregnancy. Serum calcium levels were significantly 
lower among eclamptics than controls (2.0 ± 0.4 mmol/L, Vs 2.3 ± 
0.2 mmol/L, P < 0.05). The eclamptics had higher frequency of  
hypocalcaemia than the controls (40% Vs 6.6%; OR = 14, 95% CI = 
1.58 – 316.9, P = 0.01). Serum magnesium levels were similar 
between the two groups. The conclusion of the study is eclampsia is 
associated with maternal hypocalcaemia.  
Malas NO, Shurideh ZM 26 did a study to  determine whether 
there is difference between the serum calcium of preeclampsia and 
normal pregnancy. Eighty pregnant women were enrolled in this 
study, 50 women represented the study group (Pregnancy – 
induced hypertension), and 30 women represented the control 
group (normal pregnancy). This study was carried out between 
March 1998 and February 2000 at King Hussein Medical center, 
starting from the first or 2nd trimesters and once the patient 
developed hypetension for the first time in the III trimester. The 
mean serum total calcium of the study group was (8.22 ± 0.12 
mg%). While the mean serum total calcium of the control group was 
(9.50 ± 0.16 mg %). The result was statistically lower in the study 
group (P < 0.005). The conclusion of the study is that it has been 
widely documented that there is a relationship between low 
calcium level and pregnancy induced hypertension. Therefore 
calcium supplementation during late pregnancy may be used to 
help in the prevention of this disorder.  
Hassan TJ, Sadaruddin A et al.,27 did a study to compare the 
serum levels of Calcium in preeclampsia and normal pregnant 
women. They determined serum calcium in 100 normal pregnant 
women and 50 patients with pre-eclampsia. Serum calcium levels 
were signficantly lower in patients with pre-eclampsia. Low  levels 
were found as early as 28 weeks and can therefore be used for early 
diagnosis of  preeclampsia.  
Kosch M, Hansberg M et al., 28 did a  study to compare 
plasma calcium of patients with pre-eclampsia. 18 untreated, 
healthy pregnant women and 16 pregnant nulliparous women with 
manifest pre-eclampsia were included. Plasma calcium 
concentrations were significantly lower in pre-eclamptic women 
(1.96 ± 0.l5 mmol/L, P < 0.01) compared to women with 
uncomplicated pregnancies (2.20 ± 0.10 mmol/L). 
Gao S, Liu G et al.,29 did a study to analyse the metabolism of 
serum calcium in patients with pregnancy induced hypertension. 
37 patients with obvious pregnancy induced hypertention, 56 
normal pregnant women in the same age groups were tested on 
their serum calcium. Results indicated that the respective means of 
serum calcium levels were statistically lower (P< 0.05) than that of 
normal pregnant women. It was also confirmed that calcium 
metabolism of patients with pregnancy induced hypertension was 
obviously abnormal.  
PREECLAMPSIA 
Preeclampsia is a disorder of unknown etiology. It is a clinical 
syndrome rather than a single disease. Therefore the 
pathophysiologic abnormalities of this syndrome are heterogenous 
and varies among predisposed women.  
According to the working Group of the NHBPEP 2000 
hypertensive disorders complicating pregnancy is classified as 
follows:30
1. Gestational Hypertension 
 (formerly Pregnancy induced hypertension that 
included transient hypertension) 
2. Preeclampsia 
3. Eclampsia 
4. Preeclampsia superimposed on chronic hypertension 
5. Chronic hypertension 
DEFINITION  
Gestational Hypertension 
• BP ≥ 140 / 90 mm Hg for first time during pregnancy. 
• No proteinuria 
• BP returns to normal < 12 weeks’ postpartum. 
• Final diagnosis made only postpartum 
• May have other signs or symptoms of preeclampsia. 
Preeclampsia  
 Minimum criteria 
• BP ≥ 140 / 90 mm Hg after 20 weeks’ gestation 
• Proteinuria ≥ 300 mg / 24 hours or ≥ 1 + dipstick  
Increased certainty of preeclampsia 
• BP ≥ 160 / 110 mmHg 
• Proteinuria 2g/24 hours  or ≥ 2 + dipstick 
• Serum creatinine  > 1.2 mg / dl unless known to be 
previously elevated.  
• Platelet < 1,00,000 / mm3 
• Microangiopathic hemolysis (increased LDH) 
• Elevated ALT or AST 
• Persistent headache or other cerebral or visual 
disturbance. 
• Persistent Epigastic pain.  
Eclampsia  
• Seizures that cannot be attributed to other causes in a 
women with preeclampsia.  
Superimposed preeclampsia on Chronic hypertension 
• New onset proteinuria ≥ 300 mg / 24 hours in 
hypertensive women but no proteinuria before 20 
weeks’ gestation.  
• A sudden increase in proteinuria or blood pressure or 
platelet count < 100, 000 / mm3 in women with 
hypertension and proteinuria before 20 weeks’ 
gestation.  
Chronic Hypertension 
• BP ≥140 / 90 mmHg before pregnancy or diagnosed 
before 20 weeks’ gestation not attributable to 
gestational trophoblastic disease (or) 
• Hypertension first diagnosed after 20 weeks’ gestation 
and persistent after 12 weeks’ postpartum.  
ACOG CLASSIFICATION OF HYPERTENSION DURING 
PREGNANCY  
1. Pregnancy  induced hypertension 
1.1 Transient Hypertension 
1.2 Preeclampsia  
a) Mild 
b) Severe 
1.3 Eclampsia. 
2. Pregnancy aggravated hypertension 
2.1 Superimposed preeclampsia 
2.2 Superimposed Eclampsia 
3. Coincidental hypertension 
INCIDENCE  
 Incidence of preeclampsia is 5 – 8%.31 In India the incidence 
is 7–9%. In The Institute of Social Obstetrics and Government 
Kasturba Gandhi Hospital the incidence is around 8 – 9%. 
RISK FACTORS FOR PREECLAMPSIA 
 Primigravida 
 Increasing maternal age32
High altitude33
Low socioeconomic status 
Chronic hypertension 
Multiple gestation34
Obesity35
Factors with reduced risk of Hypertension  
Smoking36
Placenta Previa37
Hypertension  
Hypertension during pregnancy is diagnosed when the 
resting blood pressure is 140/90 mmHg or greater; Korotkoff phase 
V is used to define diastolic pressure (Brown MA and Buddle ML 
1998; Perry IJ, 1996).38,39
Edema  
Edema is abandoned as a diagnostic criteria, because it 
occurs in too many normal pregnant women to be discriminant.40 
Proteinuria 
Proteinuria is an important sign of preeclampsia. Chesley, 
198541 concluded that the diagnosis of preeclampsia  is questionable 
in its absence. Significant proteinuria is defined by 24 hour urinary 
protein exceeding 300 mg per 24 hours or persistent 30 mg / dl (1+ 
dipstick) in random urine samples. Proteinuria is a sign of 
worsening hypertensive disease.42 
Proteinuria is assessed by dipstick method.  
 Protein  Trace  0.1 gm / L 
   1+  0.2 gm / L 
   2+  1 gm / L 
   3+  3 gm / L 
   4+  10 gm / L 
 INDICATORS OF SEVERITY OF HYPERTENSIVE DISORDERS 
OF PREGNANCY 
Abnormality Mild Severe 
Diastolic BP < 100 mm Hg 110 mm Hg or 
higher 
Proteinuria Trace to 1+ Persistent 2+ or 
more 
Headache Absent Present 
Visual Disturbance Absent Present 
Upper Abdominal Pain Absent Present 
Oliguria Absent Present 
Convulsion Absent Present 
Serum Creatinine Normal Elevated  
Thrombocytopenia Absent Present 
Liver Enzymes elevation Minimal Marked 
Fetal growth restriction  Absent Present 
Pulmonary edema Absent Present 
 
ETIOLOGY  
According to sibai 2003, currently plausible potential causes 
include the following : 
1. Abnormal Trophoblastic Invasion43, 44 
2. Immunological Factors45,46 
3. Vasculopathy and Inflammatory changes47 
4. Nutritional Factors48 
5. Genetic Factors49, 50 
Pathogenesis  
Vasospasm is the basic pathophysiology of preeclampsia.51
Endothelial cell activation has become the centerpiece in the 
contemporary understanding of the pathogenesis of preeclampsia.52
Increased pressor responses with alteration in the 
prostaglandins, Nitric oxide, Endothelins and Angiogenic factors.  
Other Systemic Effects of Preeclampsia  
Brain  - edema, hemorrhage, infarction 
Eyes  -  serous retinal detachment, cortical 
blindness, pappiledema 
CVS  -  hypertension, pulmonary edema. 
RS   -  pulmonary edema, aspiration pneumonia. 
Liver  - congestion, hemorrhage, infarction, rupture. 
Kidney  -  glomerulo endotheliosis, nephritic 
syndrome, acute renal failure. 
Blood -  thrombocytopenia, microangiopathic 
hemolytic anemia, DIC.  
Reproductive - IUGR, prematurity, placental abruption, 
fetal demise. 
Skin  -  edema, petechiae, ecchymosis. 
Mucosa  -  laryngeal edema. 
Predictors of Preeclampsia  
1. An elevated blood pressure in mid pregnancy. 
2. Roll over test at 28 – 32 weeks 
3. Angiotensin sensitivity test 
4. Measuring micro albuminuria 
5. Elevated serum uric acid levels 
6. Elevated serum Fibronectin levels 
7. Combined first – trimester serum levels of Placental 
Growth Factor (PIGF) and Soluble fms like tyrosine 
kinase - 1 (sFlt1). 
8. Screening for Fetal DNA in maternal serum during 
earlier pregnancy may be predictive of subsequent 
preeclampsia. 
9. Uterine artery doppler velocimetry.  
MAGNESIUM 
Magnesium is the fourth most abundant cation in the body 
and the most abundant intracellular cation after potassium53, 54. 
The adult human body contains approximately 20 to 28 grams of 
which 60% is found in bone, 26% in muscle and 13% in soft tissue 
and < 1% is in blood.55
Pharmacokinetics 
Normal serum levels are usually in the range 1.8-3 mg/dl 
(0.48 - 1.05 mmol/L). About half the magnesium in plasma is free, 
approximately one third is bound to albumin; and the remainder is 
complexed with citrate, phosphate or other ions. 
Magnesium is essential to life. Magnesium plays a role in 
more than 300 enzymatic reactions and is critically involved in 
energy metabolism, glucose utilisation, protein synthesis, fat 
synthesis and breakdown, ATPase functions and virtually all 
reactions.56 Magnesium is involved in maintaining cellular ionic 
balance through its association with sodium, potassium and 
calcium57. 
 It is absorbed in the ileum and colon, absorption decreases as 
intake increases. The rate of absorption varies from 35 - 45%. 
Absorbed by two mechanisms, facilitated and simple diffusion. The 
efficiency of absorption varies with the magnesium status of the 
individual and the amount of magnesium in the diet. Vitamin D 
has no effect on magnesium absorption. Parathyroid hormone 
appears to be essential for both gastro intestinal and renal tubular 
reabsorption of magnesium. Only 3-5% of filtered magnesium 
appears in urine, the rest is reabsorbed. Renal impairment may 
cause magnesium retention and leads to toxicity. 
 Many calcium channels are magnesium dependant. Higher 
intracellular magnesium concentrations inhibit calcium transport 
into the cell and from the sarcoplasmic reticulum. Therefore, in 
magnesium deficiency, intracellular calcium levels rises 
significantly. Magnesium deficiency may result in reduced 
intracellular levels of ATP and potassium and increased 
intracellular levels of sodium and calcium. 
Patient with hypomagnesemia often have calcium deficiency 
that does not respond to calcium repletion until the magnesium 
deficiency is addressed.58 While this phenomenon is partially 
explained by calcium-magnesium exchange, the primary factor 
involved appears to be parathyroid hormone, since magnesium 
deficiency impairs both the release of parathyroid hormone and its 
uptake by bone and skeletal end organ.59
Magnesium deficiency 
Magnesium deficiency refers to depletion of total body stores, 
while  hypomagnesemia describes low serum concentrations < 1.23 
mg/dl (< 0.5mmol/L) serum levels can be normal in the presence of 
low intracellular stores. 
In patients with acidosis, magnesium shifts from the 
intracellular space to extracellular space. While in alkalosis, 
magnesium shifts from the extracellular space to the intracellular 
space.60 Therefore, alkalotic patients may have low serum 
magnesium levels without total body magnesium deficiency, while 
those with acidosis may have normal serum levels despite deficient 
intracellular stores. 
Magnesium and Pregnancy 
Human pregnancy is characterized by several cardiovascular 
changes, among them a 50% increase in cardiac output, decrease in 
systemic vascular resistance, a 40% blood volume expansion, a 
decrease in mean arterial blood pressure and a 10-15 beats/min 
increase in heart rate. It is possible that alterations in magnesium 
metabolism may be responsible for some of the physiological  
changes seen during pregnancy and in many disease related to 
cardiovascular abnormalities. Magnesium has been used 
extensively in obstetrics for the treatment of alteration of uterine 
contractility (Premature labor) or increased neuronal and vascular 
smooth muscle activity (pre-eclampsia).61  
Electrolyte deficiencies 
Patients with electrolyte deficiencies are at increased risk of 
magnesium deficit. Measuring serum magnesium in hospitalised 
patients with one electrolyte abnormality detected 
hypomagnesemia in 42% of hypokalemic patients, 29% of those 
with hypophosphatemia, 23% of those with hyponatremia and 22% 
of those with hypocalcemia. 
Any electrolyte abnormality which is resistant to 
supplementation needs magnesium evaluation.58
Pre-eclampsia 
Magnesium is the agent of choice in the prevention and 
treatment of eclamptic  seizures. The primary objective of 
magnesium sulphate prophylaxis in women with pre eclampsia is 
to prevent or reduce the rate of eclampsia and complication 
associated with eclampsia.62 
Magnesium sulphate is effective in preventing and treating 
eclampsia.63 Magnesium sulphate halves the risk of eclampsia and 
probably reduces the risk of maternal death. There do not appear to 
be substantive  harmful effect to mother or baby in the short 
term.64 
Magnesuim sulfate has dual action. It interferes with 
transmission at the neuromuscular junction and also affects the 
central nervous system. Magnesium sulfate has central anti 
convulsant activity in animal model, inhibiting the N-methyl-D-
aspartate receptor in the brain.65 
CALCIUM 
Calcium is the fifth most abundant element on earth and is 
the most abundant mineral in the body. It is the principal 
extracellular divalent cation in the human body. It makes up about 
1.5 to 2% of the body weight. Ninety-nine percent of calcium is in 
the bones and teeth. The remaining 1% is in the blood and 
extracellular fluids. 
Serum Calcium 
Normal serum calcium levels ranges from 9.0 - 10.5 mg/dl 
(2.2 - 2.6 mmol/L). Three forms of calcium are in equilibrium in 
serum. Diffusible ionised calcium which account for approximately 
half of total serum calcium, non-diffusible calcium bound primarily 
to albumin accounts for 45% and diffusible complexes of calcium in 
the lactate, bicarbonate, phosphate, sulfate, citrate and other 
anions form the remaining 5%. Ionised calcium is the physiological 
active form. 
The normal serum calcium is maintained by the integrated 
actions of parathyroid hormone (PTH),66 vitamin D metabolites, 
calcitonin, and cytokines such as transforming growth factor  β and 
interluekin-6. 
A decrease in serum albumin of 1g/dl results in a decrease of 
about 0.8mg/dl in total serum calcium. The equilibrium among the 
three forms of serum calcium is affected by changes in blood  pH. 
Thus at pH 6.8 (acidosis), about 54% of serum calcium is in the 
ionized form, whereas at pH 7.8 (alkalosis), only 38% is ionized. 
Calcium is absorbed mainly in deodenum where an acid 
medium prevails. Absorption is reduced in alkaline medium. 
Usually 20 - 30% of ingested calcium is absorbed. 
Calcium is excreted in feces, urine and sweat, 130 mg / day 
calcium is excreted through feces and 2 - 4 mg/kg/day via urine and 
15mg /day of calcium is excreted via sweat. 
Fetal calcium correlate with intake. Although high urinary 
excretion has been reported to accompany high-protein diet. The 
presence of phosphorus decrease calcium excretion. 
Caffeine and theophylline intakes are also related to calcium 
excretion. Consumption of a low calcium diet plus two to three 
servings of brewed coffee resulted in a greater bone loss from the 
spine and total body calcium in healthy post menopausal women. 
(Harris and Dawson - Hughes, 1994). While caffeine consumption 
has been linked to increased risk of hip fracture in women (Kiel et 
al., 1990). Recent studies suggest that drinking one 8 oz glass of 
milk may offset the risk. 
Calcium and Pregnancy 
Because of substantive fetal needs 300mg/day and as well as 
increased renal calcium loss from augmented glomerular filtration, 
PTH levels were assumed to be increased in pregnant women. 
However Seeley and co-workers (1997)67 reported a significant 
decrease in intact parathormone level during pregnancy. At the 
same time, they showed a two fold increase in serum concentration 
of 1,25 dihydroxy vitamin D, which is probably of placental and 
decidual origin. It increases gastrointestinal absorption to meet the 
needs of pregnancy. 
Total serum calcium levels decline to parallel the decreased 
serum albumin concentrations (Power and associates 1999). 
Importantly however, ionised calcium levels are unchanged in 
pregnancy women (Dahlman and Colleagues, 1994).68 
Pregnancy – Associated Osteoporosis 
It is unlikely that normal pregnancy causes osteopenia in 
most women (Kaur and associates, 2003).69 Some women develop 
idiopathic osteoporosis while pregnant or lactating. The cause of 
this is controversial, but most authorities believe that pregnancy 
unmask preexisting bone disease70 (Black and co-workers, 2000, 
Henderson and Colleagues, 2000).71 
Idiopathic osteonecrosis of the femoral head during normal 
pregnancy has been described (Chang and associates, 1993;72 
Gribble and Berres, 2001).73 Most clinician recommend calcium and 
vitamin D supplementation. Although bone density improves in 
these women, as well as their offspring, many have chronic 
osteopenia (Blanch and Co-workers, 1994; Carbone and colleagues, 
1995).74, 75 
Hypertension 
Evidence supporting an inverse relationship between calcium 
intake and blood pressure has strengthened in the past decade. 
Both children and elderly women appear to benefit from increased 
calcium take (Gilman et al., 1992; Simon et al., 1992). Low calcium 
intake is not the only factor contributing to hypertension, but it 
does play a role. 
The role of calcium in gestational hypertension is still not 
clear. Calcium supplementation has been reported to reduce 
pregnancy-induced hypertension (Repke and Villar, 1990) and to 
have no effect in high risk population. However, supplementation 
did reduce the incidence of preterm delivery and low birth weight 
infants. 
The role of calcium to prevent pre-eclampsia is as follows. 
High dose calcium exert a negative feedback effect on parathyroid 
hormone  → lowering of intracellular calcium ion levels → smooth 
muscle relaxation and diminished responsiveness to pressor 
stimuli. 
Further more calcium supplementation is associated with 
higher levels of calcium excretion which is coupled with an ion 
exchange with magnesium resulting in increased levels of serum 
magnesium → smooth muscle relaxation in blood vessels → control 
of hypertension (Belzian et al., 1988). 
  
AIM OF THE STUDY 
To evaluate serum magnesium and calcium in the prediction 
of preeclampsia in at risk mothers. 
MATERIALS AND METHODS 
Study Design : Prospective case control study 
Study place : This study was conducted in the 
department of obstetrics at The Institute of 
Social Obstetrics and Government 
Kasturba Gandhi Hospital, Madras Medical 
College, Chennai. 
Study period : October 2006  to September 2007. 
Study Population : 
Inclusion Criteria 
1. Pregnant women of age 18 years and above 
2. Singleton pregnancy 
3. Gestational age 28-30 weeks 
4. Roll over test positive 
5.  Regular for follow up and compliant 
6. Planning to have the delivery in the same institution 
Exclusion Criteria 
1. Previous preeclampsia. 
2. Pregnant women with medical diseases complicating 
pregnancy like hypertension, diabetes, cardiac, renal, 
liver disorders, CCF. 
3. Known eplieptic patients 
4. Multiple pregnancies 
5. Pregnant women on drugs like calcium channel blocker, 
diuretics, drugs containing calcium  and magnesium. 
Study population: 
600 pregnant women with normal blood pressure at the time 
of recruitment were subjected to  roll over test and those who were 
positive for Roll over Test (288) were selected as study population. 
All these women were subjected to serum magnesium and 
calcium assay. Those who had low levels of serum calcium and 
magnesium formed the study group (95). The remaining 193 who 
had normal serum magnesium  and calcium levels were taken as 
controls. 
STUDY MANOEUVRE 
Pregnant women attending our antenatal outpatient 
department with normal blood pressure were selected. Detailed 
history and physical examination including blood pressure and 
urine for protein and other baseline investigations were done. 
Pregnant women with normal blood pressure fulfilling our study 
criteria were selected. They were subjected to roll over test. 
Blood pressure measurement: 
To ensure accurate reading, an appropriate size blood 
pressure cuff was used (i.e. 12 x 23cm for normal arm size, for arm 
size > 35cm cuff size 15 x 33cm), measured after a rest period of 10 
minutes, in sitting posture with arm at the level of the heart, 30,76 
with phase V Korotkoff sound for diastolic blood pressure. 
Roll Over Test: 
 A test in which a woman lies on her left side for 15 minutes 
after which blood pressure is recorded. She then rolls into the 
supine position and after 5 minutes, blood pressure is measured 
again. A rise in diastolic blood pressure in the supine position of 
more than 20mm Hg is defined as positive roll over test.77 
Those pregnant women with positive roll over test  were 
selected as study population. For this study population detailed 
history, physical examination and baseline investigations were 
done and recorded in a predesigned proforma. 
Heparinised venous blood of 5ml  was collected from all 
pregnant women in the study population  and analysed for total 
serum magnesium and calcium. 
All the study population were followed up till delivery. On 
each follow-up detailed clinical examination including blood 
pressure and urine for protein were done.  
Serum total magnesium concentrations were determined by 
photometric test using xylidyl blue. Magnesium ions form a purple 
coloured complex with xylidyl blue in alkaline solution. In the 
presence of glycolether diamine tetracetic acid, which complexes 
calcium ions, the reaction is specific. The intensity of the purple 
colour is proportional to the magnesium concentration. 
Serum total calcium concentration was determined by 
colorimetric test using Arsenazo - III. Calcium with Arsenazo III at 
neutral pH, yield a blue colored complex. The intensity of the colour 
formed is proportional to the calcium concentration in the sample. 
STATISTICAL ANALYSIS 
Data has been entered in excel and analysed using SPSS PC+ 
and EPI Info 2000 statistical software. 
The results were analysed by using T test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATIONS 
This prospective study was carried out at the Institute of 
social obstetrics and Govt. Kasturba Gandhi Hospital during the 
period of October 2006 to September 2007. 600 pregnant women 
attending our outpatient department were primarily screened for 
predilection for PIH based on roll over test. 288 pregnant women 
with positive roll over test were included in the study. 
TABLE - 1 
SCREENING WITH ROLL OVER TEST 
S.No Roll Over Test Number of pregnant women
 Total number of Roll Over Test  600 
1. Roll over test positive 288 
2. Roll over test negative 312 
 
Of the 600 women who were subjected to roll over test, 288 
women were roll over test positive and remaining were roll over 
test negative. Roll over test positive women were included in the 
study population. For all the women with roll over test positive, 
serum magnesium and calcium levels were measured. 
 
 
TABLE - 2 
STUDY POPULATION 
S. No. Category No. of Pregnant Women % 
1. Study  group 95 33% 
2. Control group 193 67% 
 
 
Among the 288 pregnant women with positive roll over test, 
those who had lower levels of serum Magnesium and Calcium 
developed preeclampsia were designated as study group (95) and 
those with normal levels of serum Magnesium and Calcium 
remained normotensive were designated as control group (193). 
Since our study was conducted in the hospital which caters to 
low socio economic status population and also our institute being 
tertiary centre, more cases of preeclampsia were seen. 
TABLE - 3 
AGE DISTRIBUTION 
S. No. Age (yrs) 
Control Group  
n (%) 
Study Group 
n (%) 
1. < 20 yrs 9 
 (4.6%) 
14 
(14.8%) 
2. 21 - 25 
yrs 
128  
(66.3%) 
57 
(60%) 
3. 26 - 30 
yrs 
44 
(22.7%) 
12  
(12.6%) 
4. > 31 yrs 12 
(6.4%) 
12 
(12.6%) 
 
Among the control group most of the cases were in the age 
group 21-25 years followed by 26-30 years and remaining were 
more than 31 years. 
Among the study group 14.8% were of age less than 20 years 
and 12.6% were more than 31 years. This observation shows that 
either end of reproductive age are more susceptible of 
preeclampsia. Youngest in this study was 19 years and eldest was 
37 years. Most of the cases were in the age group 21 - 25 years. 
 
TABLE  - 4 
PARITY DISTRIBUTION  
S. No. Parity 
Control Group 
n (%) 
Study Group 
n (%) 
1. Primi 126 
(65.2%) 
72 
(75.7%) 
2. G2 34 
(17.6%) 
20 
(21.1%) 
3. G3 25 
(12.9%) 
3 
(3.2%) 
4. G4 8 
(4.3%) 
0 
 
Among the control group 65.2% were Primi, 17.6% were 2nd 
gravida, 12.9% 3rd gravida and 4.3% were 4th gravida. 
Among the study group 75.7% were primi. This is in 
conformity with the general incidence of preeclampsia. 21.1% were 
2nd gravida, and remaining were 3rd gravida. 
 TABLE - 5 
BOOKING STATUS 
S.No. Booking Status 
Control Group 
n (%) 
Study Group 
n (%) 
1. Booked  at Institute 
of Social Obstetrics 
& KGH 
184(95.3%) 91(95.7%) 
2. Booked  elsewhere 9(4.7%) 4(4.3%) 
3. Unbooked - - 
 
95.3% in the control group and 95.7% in the study group were 
booked at the Institute of social obstetrics and Govt. Kasturba 
Gandhi hospital and remaining were booked elsewhere and 
attended our out patient department. There were no unbooked 
cases. 
TABLE - 6 
SOCIO ECONOMIC STATUS78 
S. No. 
Socio economic 
status 
Control Group 
n (%) 
Study Group 
 n (%) 
1. Class I - - 
2. Class II - - 
3. Class III - - 
4. Class IV 8(4.2%) 3(3.2%) 
5. Class V 185(95.8%) 92(97.8%) 
 
Among the control group 95.8% were in class V socio 
economic status, 4.2% were belonging to class IV socioeconomic 
status. 
Among the study group 97.8% were belonging to class V 
socioeconomic status and 3.2% were from class IV socio economic 
status. This is in expected lines since our hospital essentially caters 
to population who were below poverty line. 
TABLE - 7 
BLOOD PRESSURE DISTRIBUTION 
S.No. 
Blood Pressure 
(mm Hg) 
No. of pregnant 
women 
% 
1. Systolic 100 - 128  
Diastolic 70 - 88 
193 67% 
2. Systolic 130 -158  
Diastolic 90 - 108 
61 21% 
3. Systolic  >  160 
Diastolic > 110 
34 12% 
 
Of the 288 pregnant women who were roll over test positive, 
during the course of pregnancy 67% remained normotensive with 
systolic BP in the range of 100 - 128 mm Hg, Diastolic BP 70 - 88 
mm Hg, 21% developed mild pregnancy induced Hypertension with 
systolic BP in the range of 130 - 158 mm Hg and diastolic BP 90 - 
108 mm Hg. 
12% developed severe pregnancy induced hypertension with 
the Bp range ≥ 160 / 110 mm Hg. 
TABLE - 8 
DEGREE OF PROTEINURIA 
S.No. Degree of  Proteinuria 
No. of Pregnant 
women 
% 
1. 1+ 55 19% 
2. 2+ 23 8% 
3. ≥ 3+ 17 6% 
 
19% of the pregnant women were with dipstick proteinuria 
1+, 8% with 2+ proteinuria and 6% were with proteinuria > 3+. 
TABLE - 9 
 
GA AT WHICH PRE ECLAMPSIA DEVELOPED 
S. No. 
GA at which 
preeclampsia 
developed 
No. of pregnant 
women 
% 
1. 32-34 wks 61 64.2% 
2. 35-37 wks 31 32.6% 
3. > 38wks 3 3.2% 
 
During follow up 64.2% developed preeclampsia at 32-34 wks, 
32.6% at 35-37 wks and 3.2% developed preeclampsia after 38 wks. 
TABLE - 10 
MODE OF TREATMENT 
S.No. Treatment No. of Pregnant women % 
1. AHT alone 41 43.2% 
2. AHT and MgSo4 9 9.5% 
3. No Treatment 45 47.3% 
 
Of the patients who developed preeclampsia, 41 were treated 
with Anti hypertensives (AHT) according to our hospital protocol 
and 9 patient required magnesium sulphate either as prophylactic 
or therapeutic purpose, remaining were managed expectantly. 
TABLE - 11 
MATERNAL COMPLICATIONS 
S.No. Maternal Complication
No. of pregnant 
women  
% 
1. Abruption 7 7% 
2. Eclampsia 1 1% 
3. Hellp Syndrome 0 0 
 
Among the patients who developed severe preeclampsia 7 had 
Abruption, 1 had Eclampsia. No other complications were noted. 
Since we diagnosed preeclampsia earlier and treated accordingly, 
the complications were less.  
TABLE - 12 
MODE OF DELIVERY 
S.No. Mode of Delivery 
Control group 
n (%) 
Study group  
n (%) 
1. Labour Natural 125  
(64.7%) 
66 
(69.4%) 
2. LSCS. 49 
(25.3%) 
27 
(28.4%) 
3. IVD 19 
(10%) 
2 
(2.2%) 
 
Among the control group 64.7% were delivered via 
naturalis,25.3 by Lower Segment Caesarean Section (LSCS) and 
the remaining by Instrumental Vaginal Delivery (IVD).  
Among the study group 69.4% were delivered via naturalis, 
28.4% by Lower Segment Caesarean Section (LSCS) and remaining 
by Instrumental Vaginal Delivery (IVD). 
TABLE - 13 
DISTRIBUTION OF BIRTH  WEIGHT 
S.No. Birth Weight (kg) 
Control Group 
n (%) 
Study Group 
n (%) 
1. ≤ 2 8 
(4.1%) 
7 
(7.5%) 
2. 2-2.5 20 
(10.4%) 
15 
(15.7%) 
3. > 2.5 165 
(85.5%) 
73 
(76.8%) 
 
Among the control group 4.1% of babies were less than 2 kg, 
10.4% were of weight 2 - 2.5kg and remaining babies were of weight 
more than 2.5kg. 
Among the study group 7.5% of babies were less than 2 kg, 
15.7% were of weight 2 - 2.5 kg and 76.8% were more than 2.5 kg 
weight.   
 
 
 
 
 TABLE- 14 
FETAL COMPLICATIONS 
S.No. Fetal Complications 
Control Group 
n(%) 
Study Group 
n(%) 
1. IUGR 4 
(2%) 
4 
(4.2%) 
2. Preterm 6 
(3.1%) 
7 
(7.3%) 
3. Respiratory Distress 8 
(4.1%) 
7 
(7.3%) 
4. IUD - - 
 
Among the control group 2% has Intra Uterine Growth 
Retardation (IUGR) babies 3.1% has preterm delivery and 4.1% 
had respiratory distress. 
Among the study group 4.2% had Intra Uterine Growth 
Retardation (IUGR) babies, 7.3% had preterm delivery and 7.3 
babies had Respiratory distress. There was no Intra Uterine death 
noted. 
 
TABLE - 15 
MEAN SERUM MAGNESIUM AND CALCIUM LEVELS 
S.No Category 
Number 
of cases
Serum 
magnesium 
(mg/dl) 
Serum Calcium 
(mg/dl) 
1 Control Group 193 2.27 ± 0.12 11.02 ± 0.45 
2 Study Group 95 1.43 ± 0.10 8.62 ± 0.30 
 
Normal Serum Magnesium is 1.8 - 3 mg / dl.  Normal Serum 
Calcium 9 - 11 mg / dl. 
The mean serum magnesium level in the control group was 
2.27 ± 0.12 mg / dl and mean serum calcium level was 11.02 ± 0.45 
mg / dl. Those who had normal level remained normotensive in the 
follow up. 
The mean serum magnesium level in the study group was 
1.43 ± 0.10 mg /dl and mean serum calcium level was 8.62 ± 0.30 
mg / dl. Those who had low levels developed preeclampsia in the 
follow up. 
  
TABLE - 16 
COMPARISON OF SERUM MAGNESIUM LEVELS IN  
CONTROL AND STUDY GROUP 
S.No Category 
Number 
of cases 
Serum 
Magnesium 
mean ± S.D 
(mg/dl) 
Unpaired 
 T test  
T value 
P 
value 
1 Control 
Group  
193 
2.27 ± 0.12 
2 Study Group 95 1.43 ± 0.10 
58.59 <0.001
 
The mean serum magnesium level in the study group who 
developed preeclampsia were lower than the control group who 
remained normotensive (1.43 ± 0.10 mg/dl Vs 2.27 ± 0.12 mg/dl, P 
<0.001), which is statistically significant. 
 TABLE - 17 
COMPARISON OF SERUM CALCIUM LEVELS IN  
CONTROL AND STUDY GROUP 
S.No Category 
Number 
of cases
Serum Calcium 
mean ± S.D 
(mg/dl) 
Unpaired 
 T test  
T value 
P 
value 
1 Control Group 193 11.02 ± 0.45 
2 Study Group  95 8.62 ± 0.3 
52.95 <0.001
 
The mean serum calcium level in the study group who 
developed preeclampsia were lower than the control group who 
remained normotensive (8.62 ± 0.30 mg/dl Vs 11.02 ± 0.45 mg/dl, P 
<0.001), which is statistically significant. 
DISCUSSION 
This prospective study was carried out at the Institute of 
Social Obsterics and Government Kasturba Gandhi Hospital in 600 
pregnant women attending our outpatient department. All  were  
subjected to roll over test.  288 women were roll over test positive. 
Table 1,2 : Serum Magnesium and calcium levels were 
analysed in these 288 women with positive roll over test.  Of these 
95 who had low levels of serum Magnesium and Calcium levels 
were designated as study group and those who had normal levels of 
serum Magnesium and calcium were designated as control group. 
95 of those with low levels of serum Magnesium and calcium 
developed preeclampsia during the course of pregnancy and 193 of  
those with normal  levels of serum Magnesium and  calcium 
remained normotensive during  the course of pregnancy. 
Table 3 : Most of the patients who developed preeclampsia 
were in the age group less than 25 years (74.8%). This is in 
conformity with the general incidence where preeclampsia is more 
common in the younger age group. 
According to Hauch and Lehmann 1934, preeclampsia is 
more common in the younger age group(65%)79. 
Table 4 : Most of the patients in the study group who 
developed preeclampsia were primigravida (75.7%). 
This is in conformity with other studies like that of Mac 
gillivray which showed  15 times higher incidence in primi (Mac 
gillivray 1959)80. 
Similarly Trupin et al also concluded primi to be at risk for  
preeclampsia than multipara (Trupin et al, 1996). 
Similarly Templeton and Campbell 1979, concluded primi 
with higher incidence of preeclampsia(65-75%).79 
Hauth JC, Ewell MG et al., also concluded primi to have 
higher incidence of preeclampsia(7%).79 
Table 5 : 95.7% of the patients were booked at the Institute of 
Social Obstetrics and Government KGH, 4.3% were booked 
elsewhere. There were no unbooked cases. This may be due to 
increasing health awareness in the population and governments’ 
effort in maternal and child health and partly may be due to the 
study conducted at the tertiary level. 
Table 6 : 97.8% of the patients were belonging to Class V 
socioeconomic status. It is because our Institute largely caters to 
population below poverty line. According to Duffus and Mac 
Gillivray 1968, preeclampsia is common in poor socioeconomic 
class.79 
Table 7 : In our study during follow up, 67% remained 
normotensive, nonproteinuric, 21% developed mild preeclampsia 
and 12% developed severe preeclampsia. 
Table 8 : 19% of the patient were with 1+ dipstick 
proteinuria, 8% with 2+ and 6% with proteinuria > 3+.  Chesley 
1985 concluded that diagnosis of Preeclampsia is questionable in 
the absence of proteinuria.41 Mc Cartney and co-workers (1971) 
invariable found proteinuria in patients with preeclampsia.81 
Table 9, 10 : During follow up 64.2% developed preeclampsia 
at 32-34 weeks, 32.6% at 35-37 weeks and 3.2% developed 
preeclampsia after 38 weeks.  41 of those who developed 
preeclampsia were treated with anti- hypertensive treatment alone. 
Objective of anti-hypertensive treatment is to prevent 
intracranial Haemorrhage and left ventricular failure.  (Donaldson 
JO : Neurology of pregnancy, WB saunders Co, 1987). 
9 patients in the study group were treated with Magnesium 
sulphate. Magnesium sulphate is the ideal anticonvulsant in 
preeclampsia (sibai BM et al 1990). 
Pritchard et al 1975 and Zuspan FP et al 1965 observed a 
better maternal and fetal outcome in   severe preeclampsia patients 
treated with Magnesium sulphate. 
According to Altman D, Carroli G  et al, 200764 use of 
Magnesium sulphate  do not appear to have substantive harmful  
effects to mother and baby   in the short term. 
The success of magnesium therapy as a treatment for  
eclamptic  seizures and the known effect of   magnesium on 
vascular  response invitro  suggested that magnesium might be 
deficient in women with  preeclampsia.  This  hypothesis was 
supported by the  observation of reduced Magnesium concentration 
in serum.  (James M.Roberts, Judith  C Balk et al 2003)2 
Table 11 : In our study, of those patients who developed 
severe preeclampsia, 7% had Abruption, 1% had Eclampsia.  
In a retrospective study by Al Mulhim AA et al, placental 
abruption was more common (12.6%) followed by Oliguria (7.9%) 
and renal failure (4.1%). 
In a study by Sibai et al.,80 placental abruption was more 
common(20%), followed by HELLP syndrome (5%). 
In a study by Friedman SA et al.,80 of those with severe  
preeclampsia (5%) had placental abruption and (9%) had 
Eclampsia. 
Table 12 : In the normotensive group 64.7% delivered via 
naturalis and remaining by Lower Segment Caesarean Section 
(LSCS) and Instrumental Vaginal Delivery (IVD). Among the 
preeclamptic group 69.4% had labour natural, 28.4% by caesarean 
section and 2.2% by Instrumental delivery. 
In a study by AL Mulhim AA et al 68.4% had vaginal 
delivery, remaining had Instrumental Vaginal Delivery (IVD) and 
Caesarean Section. 
Similar results were observed by Cunningham et al,1993.82 
Table 13,14 : 23% of the babies were of birth weight less than 
2.5 kg; of these 4% were IUGR babies and 7% were preterm. Access 
to the prenatal care, early detection of preeclampsia, careful 
monitoring and appropriate management are crucial element in the 
prevention of preeclampsia related morbidity and mortality. 
Various literature emphasizes increased risk of adverse 
neonatal outcome in the presence of proteinuria and hypertension. 
In an analysis by Buchbinder A et al found that preeclamptic 
women had higher rates of preterm delivery and small for 
gestational age. 
In a retrospective study by Al Mulhim AA et al, perinatal 
outcome in preeclamptic women showed higher still birth rate 
(2.34%) and early neonatal death (1.02%). 
In our study since we diagnosed preeclampsia earlier and 
treated accordingly,  the neonatal morbidity is less and neonatal 
mortality is nil. 
Table 15, 16, 17 : In our study women who developed 
preeclampsia had lower levels of serum Magnesium and calcium 
when compared to women who remained normotensive who had 
normal levels of serum magnesium and calcium. 
The mean serum magnesium levels in the study group who 
subsequently developed preeclampsia was 1.43 ± 0.10 mg/dl. The 
mean serum magnesium levels who remained normotensive 
(control group) was 2.27 ±0.12 mg /dl. 
The mean serum calcium levels in the women who 
subsequently developed preeclampsia (study group) was 8.62 ± 0.30 
mg/dl. The mean serum calcium levels in the women who remained 
normotensive (control group) was 11.02 ± 0.45 mg /dl. 
Similar results were observed in the following studies : 
According to S.R. Ambwani, UH Shah et al.,15 the serum 
magnesium and calcium levels were lower in  women with 
preeclampsia when compared to normotensive pregnant women.  
Serum magnesium levels were (1.34 ± 0.06 meq/l vs 2.06 ± 0.67 
meq/l, P<0.001) serum calcium levels were (7.76 ± 0.37mg / dl vs 
9.24 ± 0.15 mg/dl, P<0.01). 
 According to Sukonpan K, Phupong V study16, the serum 
magnesium levels were lower in  women with Preeclampsia than 
normotensive pregnant women (0.77 ± 0.08 mmol/l vs 0.85 ± 0.09 
mmol/l, P = 0.001).  Serum calcium levels were lower in  women 
with Preeclampsia compared to normotensive pregnant women (9.0 
± 0.4 mg/dl vs 9.7 ± 0.7 mg/dl, P < 0.0001). 
According to Kisters K, Niecher W 83, the serum magnesium 
levels were lower in Preeclamptic women when compared to 
normotensive pregnant women  (1.31 ± 0.16 mg / dl vs 1.83 ± 0.29 
mg / dl, P < 0.001). 
In a study by J Kar, R.Jina 84 the serum magnesium levels 
were found to be lower in women with Preeclampsia compared to 
pregnant women who remained normotensive (1.51 ± 0.21 mg/dl vs 
2.12 ± 0.19 mg/dl, P < 0.001). 
In the study by Malas NO, Shurideh ZM26 also the serum 
calcium levels in  women with Preeclampsia were lower compared 
to normal pregnant women (8.22 ± 0.12 mg% vs 9.50 ± 0.16 mg%, P 
< 0.005). 
 According to Kosch M, Hausberg M et al.,28 the serum 
calcium levels in women with Preeclampsia were lower than the 
levels in normal pregnant women (1.96 ± 0.15 mmol/l vs 2.20 ± 0.10 
mmol / l, P < 0.01). 
Lower serum magnesium and calcium levels is statistically 
significant in predicting the Preeclampsia in at risk mothers. 
SUMMARY 
This prospective study “Evaluation of Serum Magnesium and 
Calcium in the prediction of Preeclampsia in at risk mothers “was 
carried out at the Institute of Social Obstetrics and Government 
Kasturba Gandhi Hospital for women and children , Chennai 
during the period October 2006 to September 2007. 
Observations of this study includes: 
 Most of the patients in the study group were in the age group 
21-25 years. 
 75.7% of the patients were primigravida. 
 95.7% of the cases were booked at the Institute of  Social 
Obstetrics and Govt Kasturba Gandhi Hospital. 
 97.8% belong to class V socio economic status. 
 21% developed mild preeclampsia and 12% developed severe 
preeclampsia. 
 Of those who developed preeclampsia 64.2% developed 
preeclampsia at 32-34 weeks of gestation, 32.6% developed 
preeclampsia at 35-37 weeks and 3.2% developed 
preeclampsia after 38 weeks. 
 Of those who developed preeclampsia, 41 were treated with 
Antihypertensives alone and 9 were treated with magnesium 
sulphate. 
 Of the 12% who developed severe preeclampsia 7 had 
Abruption and 1 had Eclampsia. 
 69.4% were delivered via Naturalis, 28.4% by caesarean 
section and 2.2% by Instrumental vaginal delivery. 
 The mean serum magnesium levels in the study group who 
subsequently developed preeclampsia was 1.43 ± 0.10 mg/dl. 
The mean serum magnesium levels who remained 
normotensive (control group) was 2.27 ±0.12 mg /dl. 
 The mean serum calcium levels in the women who 
subsequently developed preeclampsia (study group) was 8.62 
± 0.30 mg/dl. The mean serum calcium levels in the women 
who remained normotensive (control group) was 11.02 ± 0.45 
mg /dl. 
 Lower Serum Magnesium and Calcium levels are statistically 
significant in predicting Preeclampsia for at risk mothers.  
 
CONCLUSION 
 Preeclampsia is a multisystem disorder unique to pregnancy.  
 Any method which can reasonably indicate the possibility of 
developing Preeclampsia will be most welcome. 
 One such method developed is the measurement of serum 
magnesium and serum calcium estimation.  
 This study conducted at The Institute of Social Obstetrics 
and Govt. Kasturba Gandhi Hospital reveals estimation of 
serum calcium and magnesium levels to be a useful indicator 
for the prediction of preeclampsia. 
 This low cost technique is ideally suited as a screening test 
for women even in resource poor settings like India. 
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PROFORMA 
Serial No. 
O.P. No/IP No. 
Unit   
Name   Age  Address  Socio Economic 
status 
Booked / Booked outside / Unbooked : Marital status : 
Unmarried/Married 
Immunized : Yes/No 
Obstetric History : Gravida  Para  Live  Abortion 
    LMP  : 
    EDD : 
Personal History : Diet, Smoking 
 H/o Diabetes mellitus, hypertension , renal 
disease, cardiac disease, liver disease, 
congestive cardiac failure, epilepsy. 
    H/o Preeclampsia in the previous pregnancies 
Family History : H/o preeclampsia in the mother, sisters 
    H/o diabetes, hypertension 
Drug History : H/o taking any calcium channel blockers, 
diuretics, drugs containing magnesium and 
calcium. 
Symptoms  : Duration of pedal edema, facial puffiness  
    H/o oliguria, urinary tract infection. Signs and 
symptoms of imminent eclampsia like 
headache, giddiness, vomiting, visual 
disturbances, abdominal pain. 
General Examination 
 Height Weight Anemia 
 PR 
 BP    
 Breast, Thyroid, spine 
 CVS  RS CNS 
Per abdomen 
Roll over test  : Positive / Negative 
Investigations 
  Albumin 
Urine 
  Sugar 
Hb%   Urea 
Blood   Sugar 
   Creatinine 
LFT 
Serum total calcium 
Serum total magnesium 
Follow up BP 
USG 
Treatment : Anti Hypertensive Treatment (AHT) 
  Magnesium Sulphate 
Mode of Delivery : Labour Natural / Instrumental Vaginal 
Delivery (IVD) / LSCS 
Adverse maternal outcome : 
Adverse Fetal outcome : 
 
